Today's Healthcare Pulse
Pharma Shifts Ad Spend to Spot TV Amid Heightened FDA Scrutiny
Pharmaceutical advertisers are redirecting dollars toward spot television placements as the FDA intensifies its oversight of drug marketing. The trend reflects a strategic move to capture audiences with shorter, targeted ads while navigating tighter regulatory expectations.
Also developing:
By the numbers: Apogee Therapeutics secures $1.3B royalty financing
AI Meets Olfaction: SpotitEarly Unveils LUCID 2.0, Scaling Early Cancer Detection to Millions
SpotitEarly introduced LUCID 2.0, a bio‑AI hybrid platform that pairs trained detection dogs with a multi‑modal sensor array and deep‑learning algorithms to deliver breath‑based cancer screening at clinical scale. The system can process up to 1.73 million tests per year per center and provides a 0‑to‑100 confidence score for each sample. In a double‑blind study of 1,300 participants, the platform achieved 94% sensitivity across breast, lung, colorectal and prostate cancers. SpotitEarly is now expanding with a 2,000‑patient breast‑cancer trial and a lung‑cancer study, while offering a fully automated end‑to‑end workflow from mobile app to physician‑signed result.
Medix Launches Executive Search Practice Focused on Revenue Cycle Leadership
Medix announced a new executive‑search practice dedicated to senior revenue‑cycle leadership roles in healthcare. The service uses a retained, commitment‑based model that prioritizes exclusive, high‑touch engagements. By proactively mapping passive talent, Medix aims to fill critical positions that are hard...
Extensive Range of Independently Verified Cell Lines
AMSBIO has launched a new portfolio of authenticated cell lines spanning tumors, tissues and multiple species. Each line is rigorously authenticated, sterility‑tested and mycoplasma‑free, with full passage documentation to ensure traceability. The offering supports research areas such as gene activation,...
Monroe Capital Backs Warburg Pincus Investment In Cornerstone Caregiving
Monroe Capital has arranged a senior credit facility to fund Warburg Pincus’s investment in Cornerstone Caregiving, a rapidly expanding home‑based hospice and palliative care provider. Cornerstone, founded in 2020, now operates hundreds of locations across the United States. The deal underscores...
‘Excitement and Interest’ as Lp(a) Therapies Inch Closer
Late‑phase trials of dedicated lipoprotein(a) therapies are nearing completion, with the phase 3 Lp(a)HORIZON trial of pelacarsen slated for readout in the second half of 2026. Multiple modalities—including antisense oligonucleotides, siRNA agents, oral small‑molecule inhibitors, CETP inhibitors, and gene‑editing platforms—have demonstrated...
MASH Care Demands More Than New Drugs: Meena Bansal, MD
Two FDA‑approved drugs—semaglutide (Wegovy) and resmetirom (Rezdiffra)—have reshaped the therapeutic landscape for metabolic dysfunction‑associated steatohepatitis (MASH) as of 2025. Both agents target distinct pathways, with semaglutide improving fibrosis and resmetirom offering a liver‑directed approach for moderate to severe fibrosis. Dr....
How Terrorism Imperils Pakistan’s Polio Eradication Efforts
Gunmen attacked a police escort for polio vaccinators in Hangu, Khyber Pakhtunkhwa, killing one officer and wounding four. Pakistan, one of only two polio‑endemic countries, reported three wild‑polio cases in 2026, all in high‑risk provinces that overlap with terrorist hotspots....
Paclitaxel
Paclitaxel (Taxol®) received its first FDA approval in 1992 for ovarian cancer and has since become a cornerstone therapy for breast, lung and other solid tumors. The drug is a natural product isolated from the bark of the Pacific yew...
The AI Arms Race in the Revenue Cycle
Hospitals are turning to AI‑driven coding and documentation tools to stem a surge in payer claim denials that lifted net‑revenue leakage by 25% in 2025, according to Kodiak Solutions. Insurers, led by AI‑enhanced audit engines, are processing claims faster and...
DD01, Pemvidutide Data Suggest Dual Agonists Target MASH Directly: Mazen Nourredin, MD
Phase‑2 trials of the dual GLP‑1/glucagon agonists DD01 and pemvidutide revealed significant reductions in liver‑fat content and stiffness in patients with metabolic dysfunction‑associated steatohepatitis (MASH). DD01 achieved a 30% MRI‑PDFF reduction in 76% of participants by week 12, even though average...
HIMSS Sets an AI-Centered Clinician Learning Agenda
In 2026 the HIMSS Physician Committee will center its agenda on educating clinicians about artificial intelligence and analyzing successful AI deployments across health systems. HIMSS is hosting a one‑day AI Executive Leadership Summit in Boston on June 24, followed by a...
After Eric Tennant’s Death, West Virginia Takes Aim at Prior Authorization
West Virginia enacted a law allowing beneficiaries of the state employee health plan to switch to an alternative medically appropriate treatment of equal or lesser cost without restarting the prior‑authorization process. The legislation was spurred by the death of coal‑mining...
MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy
Veradigm’s 2026 Women’s Health Report shows hormone replacement therapy (HRT) use among eligible women 50 years and older rebounded to 11% in 2024, roughly double the 2020 level after a decades‑long decline. The decline traced back to the early‑2000s Women’s Health...
New Oversight Layers Needed as AI Evolves at Pace
Artificial intelligence is advancing faster than existing governance structures, prompting calls for stronger oversight across clinical and operational workflows. Dr. Ryan Sadeghian, CMIO at the University of Toledo, warns that without multi‑layered frameworks, AI tools could jeopardize patient safety and...
Judge Dismisses BCBS Texas’ Surprise Billing Lawsuit Against HaloMD
Federal Judge Robert W. Schroeder III dismissed Blue Cross Blue Shield of Texas’s lawsuit against billing intermediary HaloMD, ruling that courts lack authority to review arbitration decisions under the No Surprises Act. The ruling marks the fourth federal dismissal in...
Augurex Named ADLM 2026 Disruptive Technology Award Finalist
Augurex Life Sciences Corp. has been named a finalist for the ADLM 2026 Disruptive Technology Award for its SPINEstat® Anti‑14‑3‑eta Multiplex test, a first‑in‑class diagnostic for axial spondyloarthritis (axSpA). The company will present the technology at the ADLM conference in...
Biohub Open-Source AI Model Targets Protein Design for Drug Discovery
Biohub, part of the Chan Zuckerberg Initiative, launched an open‑source AI system that models protein biology at evolutionary scale to aid early‑stage drug discovery. The platform, described as a “world model,” was used to design protein binders targeting cancer and...
Future of Wearables: AI, Continuous Monitoring, Miniaturization
The Evolution of Digital Health Devices https://t.co/4WYg9DEZVI This short, executive-style e-book explores the transformation of fitness trackers, ECGs, blood pressure monitors, stethoscopes, sleep trackers and smart rings. Through clear timelines and practical insights, it reveals the trends shaping the next decade...
Rising Colon Cancer in Young Adults Calls for Easy Screening
Colorectal cancer cases are on the rise, and young adults are not immune. Updated guidelines recommend increased screening. In addition to colonoscopies, we should utilize easier tests more often, like the at-home stool Cologuard test and the Galleri multi-cancer early detection...
Vanda’s Imsidolimab Wins Orphan‑Drug Designation in Japan for Rare Psoriasis
Vanda Pharmaceuticals announced that Japan’s Ministry of Health, Labour and Welfare has granted orphan‑drug designation to its IL‑36 inhibitor imsidolimab for generalized pustular psoriasis (GPP). The designation unlocks development subsidies and up to ten years of market exclusivity, a pivotal...
FDA Drug Competition Action Plan | Improving the Efficiency of the Generic Drug Development, Review, and Approval Process
The FDA’s Drug Competition Action Plan (DCAP) is rolling out a series of new and revised guidances aimed at streamlining generic drug development, review, and approval. Recent releases include May 2026 bioequivalence guidance with pharmacokinetic endpoints and October 2024 product‑specific guidances aligned...
Amarin Unveils RW‑ApoB Biomarker to Pinpoint Cardiovascular Risk at EAS Congress
Amarin Corporation introduced a risk‑weighted apolipoprotein B (RW‑ApoB) biomarker at the European Atherosclerosis Society Congress, citing post‑hoc REDUCE‑IT data that could reshape cardiovascular risk stratification. The move challenges the long‑standing reliance on LDL‑C levels and may influence treatment pathways for...
Md. County Reverses Course, Approves Whole Blood Program for Trauma Patients
Somerset County, Maryland, voted unanimously to launch a whole‑blood program for trauma patients, reversing a month‑old opposition. The initiative will be funded by a state grant of $58,338 per year for five years, allowing ambulances to carry unseparated blood for...
Massachusetts ACA Enrollment Plummets as Federal Subsidies End, Threatening Coverage for Millions
Massachusetts' health insurance marketplace saw a dramatic enrollment drop after the expiration of expanded federal subsidies, with about 60,000 residents losing aid and premiums rising 7‑12%. The loss of younger and low‑income enrollees threatens risk pools and could push premiums...
Brooklyn Clinic Owner Convicted in $52 Million Medicare Suboxone Kickback Scheme
Tony Brown-Arkah, owner of American Medical Centers in Brooklyn, was found guilty by a federal jury of orchestrating a $52 million Medicare and Medicaid fraud scheme that used illegal Suboxone kickbacks and bogus medical claims. The verdict underscores intensified federal scrutiny...
The Next Useful Layer in Radiology AI Is Patient Comprehension
Radiology AI is moving beyond autonomous diagnosis toward a patient‑facing translation layer that converts complex imaging reports into plain language. While the 21st Century Cures Act has accelerated instant result access, most patients lack the health literacy to interpret the...
A $4 Tongue Swab Test Detects Tuberculosis Within 30 Minutes
Researchers have unveiled MiniDock MTB, a portable $400 device that uses $4 tongue‑swab tests to detect tuberculosis in 12‑25 minutes. The World Health Organization endorsed the test in March, marking the first official approval for a community‑based TB assay requiring minimal...
Philips Partners with Disney to Scale Ambient Experience for MRI Globally
Philips and The Walt Disney Company have launched a global partnership to embed Disney characters and storylines into Philips’ Ambient Experience platform for MRI suites in 87 countries. A multi‑center European study found that Disney‑themed audio‑visual environments cut pediatric stress...
Traws Pharma Announces New Antiviral Program
Traws Pharma announced a new antiviral development program aimed at emerging RNA viruses and other high‑risk pathogens. The initiative earmarks roughly $200 million over the next five years to fund pre‑clinical research, platform technology, and early‑stage clinical trials. The company is...
Signs of Post-Viral Depression Found in Our Immune System for the First Time
Researchers at biotech firm Tuning Fork analyzed saliva IgA antibodies from pandemic‑era volunteers and identified distinct immune signatures in individuals experiencing post‑COVID depression. The findings suggest that a subset of post‑viral depression may have measurable biological markers, moving beyond purely...
Use of Ultra-Rapid Insulin Plus MiniMed 780G Raises Time in Range
A single‑arm trial of 211 participants with type 1 diabetes showed that pairing Eli Lilly’s ultra‑rapid insulin lispro‑aabc (Lyumjev) with Medtronic’s MiniMed 780G hybrid closed‑loop system significantly boosted time‑in‑range. Children achieved a mean TIR of 68.6% (up from 51.2%) and adults reached...
Statistical Approaches to Establishing Bioequivalence
The FDA has released a final guidance titled “Statistical Approaches to Establishing Bioequivalence,” superseding the 2001 version and formalizing the December 2022 draft. The document outlines recommended statistical methods for bioequivalence (BE) assessments across INDs, NDAs, ANDAs, and related amendments. It...
Vertex’s Journavx Made History, but Left a Void in the Pain Space
Vertex Pharmaceuticals secured FDA approval for Journavx, the first novel non‑opioid pain drug in decades, amid the ongoing opioid crisis and Purdue Pharma’s recent multi‑billion‑dollar settlement. The medication targets the NaV1.8 sodium channel and quickly reached one million prescriptions, but...
Lung Cancer Risks Increase with Cannabis Use Disorder
A new retrospective cohort study of nearly 150,000 patients with cannabis‑use disorder found a 3.9‑fold increased risk of lung cancer compared with matched controls. The elevated risk was consistent across adenocarcinoma, squamous‑cell and small‑cell subtypes. Prior meta‑analyses showed no clear...
Message by the WHO Director-General to the People of the Democratic Republic of the Congo
World Health Organization Director‑General Tedros addressed the people of Ituri, DRC, announcing that the province is bearing the brunt of the country’s 17th Ebola outbreak, with over 90% of cases there. The outbreak is caused by the Bundibugyo strain, for...
3D-Printed Lymph Nodes Could Widen Access to CAR T-Cell Therapy
Researchers have shown that 3D‑printed lymph‑node scaffolds can grow CAR‑T cells more quickly and at a lower cost. The bioprinting method compresses the manufacturing timeline from several weeks to just a few days, potentially cutting expenses by up to 70...
US Abortion Restrictions Are Hindering Access to Miscarriage Care, Study Finds
A JAMA study of 123,598 privately insured patients shows that states enforcing post‑Dobbs abortion bans have shifted miscarriage care away from medication toward expectant management, with a 2.8‑percentage‑point rise in wait‑and‑see approaches and a 2.2‑point drop in medication use. In...
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
Conavi Medical Corp. secured FDA 510(k) clearance for its next‑generation Novasight™ Hybrid intravascular imaging system, integrating IVUS and OCT into a single workflow. The company also earned the 2026 MedTech Breakthrough and TAG Innovation awards, underscoring the technology’s clinical promise....
Bihar Govt Approves Cashless Healthcare Scheme for Employees and Pensioners
The Bihar government approved a cashless health scheme that will let state employees, pensioners, their families and certain officials receive indoor medical treatment without paying up front. Beneficiaries will be issued health cards, and hospitals will be reimbursed directly through...
Dr Reddy’s to Ring NYSE Closing Bell to Mark 25 Years of Listing
Dr Reddy’s Laboratories will ring the New York Stock Exchange closing bell on May 29, 2026 to celebrate 25 years since its historic 2001 NYSE debut—the first Asian pharmaceutical firm outside Japan to list on the exchange. Chairman Satish Reddy highlighted the milestone as proof...
Screening Guidelines Omit Many Patients at High Risk for Cancer
Researchers analyzed data from 446,795 UK Biobank participants aged 40‑70 and built risk models that incorporate 118 lifestyle and environmental variables for 21 common cancers. Aligning modifiable risk factors to ideal levels could lower overall cancer risk by about 9...
Ill. EMS Moves Into Firehouse to Reduce Response Times
Greene County Ambulance Service will station an advanced‑life‑support unit inside the Roodhouse Fire Protection District firehouse within two weeks. The move places two EMS personnel closer to the northern part of the county, where roughly 75% of ambulance runs originate....
One Infusion. A Permanent Gene Edit. A Lifetime of LDL Lowering. The VERVE-102 NEJM Data, the Lilly Acquisition Thesis, and...
Verve Therapeutics reported Phase 1b Heart‑2 data for its gene‑editing LDL therapy VERVE‑102 in the New England Journal of Medicine. A single intravenous infusion achieved up to 88% PCSK9 knock‑down and a 62% reduction in LDL‑C that persisted for 18...
Book Review: Unravelling MAiD in Canada: Euthanasia and Assisted Suicide as Medical Care
The newly released volume *Unravelling MAiD in Canada* provides a comprehensive legal and ethical analysis of Canada’s medical assistance in dying (MAiD) regime. Edited by physician Ramona Coelho, psychiatrist K. Sonu Gaind, and health‑law scholar Trudo Lemmons, the 552‑page work...
Medicare Underpays Office Procedures, Driving Private Practice Decline
A farm worker with gangrene got the ultrasound, the procedure, and a saved leg in a week. The hospital system that turned him away told him to wait three weeks just to be seen. Interventional radiologist Saravanan Kasthuri runs the...
AI Literacy Is Essential for Modern Healthcare Professionals
AI literacy is the new digital literacy Not optional anymore, particularly in high stakes healthcare If you work in the field, you need to start learning how to use and question AI now https://t.co/vHyjm5X60g
FDA Approves Ironwood's LINZESS for Constipation in Kids 2‑5
Ironwood Pharmaceuticals announced that the U.S. Food and Drug Administration has approved LINZESS for functional constipation in children aged 2 to 5 years. The decision adds a new pediatric indication to a drug already used by more than 5.5 million patients...
Long COVID Autoantibodies Bind Tissue, Cause Disease in Mice
Excited to share our study by @keylas3 et al. on pathological autoantibodies in people with Long COVID. We asked whether IgG in patients with Long COVID bind to human tissues/antigens and cause pathologies when transferred into mice. With @PutrinoLab https://t.co/tcowCufWyf...
How ASGCT and OTXL Are Working to Revive Shelved Cell and Gene Therapies
The American Society of Gene & Cell Therapy (ASGCT) and Orphan Therapeutics Accelerator (OTXL) have launched CGTxchange, an AI‑driven matchmaking platform designed to revive cell and gene therapies that were shelved for ultra‑rare diseases. By aggregating confidential and public data...
These Ebola Researchers Are Stuck in US Due to Trump’s Funding Cuts
The Trump administration terminated the NIH‑funded Centers for Research in Emerging Infectious Diseases (CREID) network, cutting roughly $82 million in funding after labeling the work “unsafe for Americans.” The network, which operated ten global sites and had built diagnostic capacity for...